What is the recommended surveillance protocol after 6 months for an adult patient who has undergone radical nephrectomy with a pathological diagnosis of adult cystic nephroma, characterized by CK (Cytokeratin)/PAX8 positive lining cyst epithelium and ER (Estrogen Receptor)/SMA (Smooth Muscle Actin) positive reactive spindle cell nodules that are CD68 positive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surveillance Protocol After Radical Nephrectomy for Adult Cystic Nephroma

For adult cystic nephroma after radical nephrectomy, follow the low-risk pT1 protocol: perform baseline abdominal imaging within 3-12 months post-surgery, then abdominal imaging is optional beyond 12 months at physician discretion, combined with annual chest X-ray (not CT) for 3 years, history and physical every 6 months for 2 years then annually to 5 years, and comprehensive metabolic panel on the same schedule. 1

Rationale for Low-Risk Surveillance Approach

Adult cystic nephroma is a benign renal neoplasm with negligible recurrence risk after complete resection. 1, 2, 3 The intensive surveillance protocols designed for Stage II-III renal cell carcinoma are inappropriate for this benign lesion. 1 Your pathology confirms the diagnosis with characteristic CK/PAX8 positive epithelial lining and ER/SMA positive stromal components, which are typical immunohistochemical findings for cystic nephroma. 4

Specific Surveillance Schedule

Abdominal Imaging

  • Baseline scan: Obtain CT, MRI, or ultrasound within 3-12 months after surgery 5, 1
  • Beyond baseline: Abdominal imaging is optional and at physician discretion, as local recurrence risk in the renal fossa is extremely low for this benign entity 5, 1
  • Modality choice: Ultrasound is acceptable for post-radical nephrectomy surveillance of benign lesions 5

Chest Imaging

  • Annual chest X-ray for 3 years, then as clinically indicated 5, 1
  • Avoid routine chest CT: Chest X-ray is preferred over CT to minimize false-positives that lead to unnecessary invasive workup in this benign condition 1, 6

Clinical Assessment

  • History and physical examination every 6 months for 2 years, then annually through year 5 5, 1
  • Focus on: surgical site complications, contralateral kidney function assessment, and general health status 1

Laboratory Monitoring

  • Comprehensive metabolic panel every 6 months for 2 years, then annually to 5 years 5, 1
  • Specifically monitor serum creatinine and estimated GFR to assess remaining kidney function 1, 6

What NOT to Do

  • Do not perform routine bone scans, brain imaging, or spine MRI in asymptomatic patients 5, 1
  • Only obtain symptom-directed imaging if clinical signs suggest pathology: bone pain, neurological symptoms, respiratory symptoms 5
  • Do not apply moderate-to-high risk RCC protocols (imaging every 3-6 months) to this benign lesion 1

Duration of Surveillance

Five years of structured follow-up is sufficient for cystic nephroma. 1 Extension beyond 5 years should be based on surgical complications or contralateral kidney concerns, not oncologic risk, as malignant degeneration is exceedingly rare. 1, 7

Key Clinical Pitfall

The CD68 positivity in your stromal nodules represents histiocytic infiltration, which is a reactive finding and does not alter the benign nature of cystic nephroma or change surveillance recommendations. 4 Do not mistake this for a more aggressive entity requiring intensive surveillance.

References

Guideline

Post-Radical Nephrectomy Surveillance for Cystic Nephroma and Mixed Stromal Tumor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases.

The American journal of surgical pathology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post-Operative Monitoring Protocol for T1a Renal Cell Carcinoma After Partial Nephrectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Cystic nephroma : a rare kidney neoplasm].

Revue medicale de Liege, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.